The China National Institutes for Food and Drug Control (NIFDC) has opened a public consultation on six technical guidelines for in vitro testing, determination for sun protection factor (SPF) and waterproof performance, as well as acute inhalatio
China
China's National Institutes of Food and Drug Control (NIFDC) is seeking comments on the formulation and revision of relevant content of the "Safety and Technical Specifications for Cosmetics".
All ordinary cosmetics (including domestically produced and imported ordinary cosmetics) that have been registered and filed for an year are required to submit annual report before March 31, 2023.
China's National Institutes for Food and Drug Control (NIFDC) proposed adding 5-[(E)-2-phenylethenyl]-2-(propan-2-yl)benzene-1, 3-diol (Benvitimod, Tapinarof) (CAS No. 79338-84-4) as a prohibited component for cosmetics.
On January 29, 2023, China's State Administration for Market Regulation (SAMR) announced that Chinese National Standard "GB 7919-1987: Procedures and methods of safety evaluation for cosmetics" will be repealed.
In January 2023, National Medical Products Administration (NMPA) of China updated the notification information of three new cosmetic ingredients (NCIs), namely Donkey oil (notified on January 4, 2023), Azelamidopropyl Dimethyl Amine (notified on J
In order to strengthen the supervision and management of cosmetics and standardise the sampling and inspection of cosmetics in accordance with the Regulations on the Supervision and Administration of Cosmetics, the Measures for the Supervision and
On January 13, 2023, China's National Medical Products Administration (NMPA) issued "Announcement on Matters Related to the Optimization of Administrative Measures for the Recordation and Inspection of General Cosmetics" with an aim to further opt
The Supervision and Administration of Enterprises' Implementation of the Main Responsibility for Quality and Safety of Cosmetics (No.
Regulations on Supervision and Administration of Enterprises in Implementing Entity Responsibility for Cosmetic Quality and Safety were released for public comment by the China National Medical Products Administration (NMPA) on November 29, 2022.